221 related articles for article (PubMed ID: 26382956)
1. The Cost-Effectiveness Analysis of Teleglaucoma Screening Device.
Thomas S; Hodge W; Malvankar-Mehta M
PLoS One; 2015; 10(9):e0137913. PubMed ID: 26382956
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis.
Thomas SM; Jeyaraman MM; Hodge WG; Hutnik C; Costella J; Malvankar-Mehta MS
PLoS One; 2014; 9(12):e113779. PubMed ID: 25479593
[TBL] [Abstract][Full Text] [Related]
3. Improved access and cycle time with an "in-house" patient-centered teleglaucoma program versus traditional in-person assessment.
Arora S; Rudnisky CJ; Damji KF
Telemed J E Health; 2014 May; 20(5):439-45. PubMed ID: 24568152
[TBL] [Abstract][Full Text] [Related]
4. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
8. Teleglaucoma: improving access and efficiency for glaucoma care.
Kassam F; Yogesan K; Sogbesan E; Pasquale LR; Damji KF
Middle East Afr J Ophthalmol; 2013; 20(2):142-9. PubMed ID: 23741133
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
12. The use of teleglaucoma at the University of Alberta.
Kassam F; Amin S; Sogbesan E; Damji KF
J Telemed Telecare; 2012 Oct; 18(7):367-73. PubMed ID: 22977196
[TBL] [Abstract][Full Text] [Related]
13. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of two inexpensive postfracture osteoporosis interventions: results of a randomized trial.
Majumdar SR; Lier DA; Leslie WD
J Clin Endocrinol Metab; 2013 May; 98(5):1991-2000. PubMed ID: 23596140
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of treating normal tension glaucoma.
Li EY; Tham CC; Chi SC; Lam DS
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3394-9. PubMed ID: 23599342
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
18. Telemedicine for Glaucoma: Guidelines and Recommendations.
Gan K; Liu Y; Stagg B; Rathi S; Pasquale LR; Damji K
Telemed J E Health; 2020 Apr; 26(4):551-555. PubMed ID: 32209001
[No Abstract] [Full Text] [Related]
19. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
Hofer F; Kauczor HU; Stargardt T
Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
[TBL] [Abstract][Full Text] [Related]
20. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
